ISRAEL’S MEDICAL ACHIEVEMENTS
Breakthrough in understanding leukemia. A mutated gene RUNX1 inherited from one parent is responsible for producing leukemia stem cells. Researchers at Israel’s Weizmann Institute have discovered that the healthy copy of the gene from the other parent is also required otherwise the leukemia cells die.
Brain cancer breakthrough. The media is reporting the discovery by Dr Regina Golan-Gerstl, of Jerusalem’s Hadassah Medical School, of hnRNP A2/B1. The protein gene is key to the most common and aggressive adult brain cancer – glioblastoma. Great news, as reported it in my 14th Aug 2011 newsletter.
Laquinimod reduces brain damage in MS patients. In Phase III trials, Israel’s Teva reported that its Laquinimod oral treatment for multiple sclerosis reduced neuro-degeneration, slowing the progression of locomotor disability in multiple sclerosis patients. Laquinimod might also help treat Crohn’s disease, lupus nephritis, Huntington’s disease and Alzheimer’s.
Americans look to Israel for Parkinson’s treatment. 1.5 million Americans, including many Jews, suffer from Parkinson’s disease. The Pittsburgh Jewish Chronicle highlights some of the many Israeli treatments.
DIY medical sensor. (Thanks to NoCamels.com) Israel’s Elfi Tech monitors your pulse rate, respiratory rate, blood pressure, blood flow and much more, non-invasively at any time with the help of a sensor smaller than a dime. It has just been selected as a finalist of the Nokia Sensing XChallenge.
Israel hosts international conference on proteins. 160 leading biomedical scientists from Israel, Europe and the US attended the ninth Jakub K. Parnas Conference entitled “Proteins – from Birth to Death” at the Hebrew University of Jerusalem. It is co-sponsored by the Biochemical societies of Israel, Poland and the Ukraine.